GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (HKSE:06821) » Definitions » Piotroski F-Score

Asymchem Laboratories Tianjin Co (HKSE:06821) Piotroski F-Score : 5 (As of Mar. 31, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Asymchem Laboratories Tianjin Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Asymchem Laboratories Tianjin Co's Piotroski F-Score or its related term are showing as below:

HKSE:06821' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Asymchem Laboratories Tianjin Co was 8. The lowest was 2. And the median was 6.


Asymchem Laboratories Tianjin Co Piotroski F-Score Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Piotroski F-Score Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 5.00 6.00 7.00 -

Asymchem Laboratories Tianjin Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 4.00 5.00 -

Competitive Comparison of Asymchem Laboratories Tianjin Co's Piotroski F-Score

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 306.304 + 233.783 + 232.534 + 254.773 = HK$1,027 Mil.
Cash Flow from Operations was 533.011 + 412.201 + 197.419 + 215.111 = HK$1,358 Mil.
Revenue was 1520.613 + 1396.863 + 1588.739 + 1777 = HK$6,283 Mil.
Gross Profit was 661.785 + 568.199 + 735.883 + 697.693 = HK$2,664 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(21620.901 + 21553.767 + 20302.154 + 20587.066 + 20593.855) / 5 = HK$20931.5486 Mil.
Total Assets at the begining of this year (Dec23) was HK$21,621 Mil.
Long-Term Debt & Capital Lease Obligation was HK$302 Mil.
Total Current Assets was HK$11,798 Mil.
Total Current Liabilities was HK$1,825 Mil.
Net Income was 717.961 + 1155.057 + 561.816 + 64.21 = HK$2,499 Mil.

Revenue was 2561.638 + 2594.968 + 1889.622 + 1577.375 = HK$8,624 Mil.
Gross Profit was 1239.957 + 1491.749 + 1075.368 + 599.85 = HK$4,407 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(20368.066 + 21124.665 + 20997.195 + 21201.201 + 21620.901) / 5 = HK$21062.4056 Mil.
Total Assets at the begining of last year (Dec22) was HK$20,368 Mil.
Long-Term Debt & Capital Lease Obligation was HK$116 Mil.
Total Current Assets was HK$13,510 Mil.
Total Current Liabilities was HK$1,970 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Asymchem Laboratories Tianjin Co's current Net Income (TTM) was 1,027. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Asymchem Laboratories Tianjin Co's current Cash Flow from Operations (TTM) was 1,358. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=1027.394/21620.901
=0.04751856

ROA (Last Year)=Net Income/Total Assets (Dec22)
=2499.044/20368.066
=0.12269422

Asymchem Laboratories Tianjin Co's return on assets of this year was 0.04751856. Asymchem Laboratories Tianjin Co's return on assets of last year was 0.12269422. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Asymchem Laboratories Tianjin Co's current Net Income (TTM) was 1,027. Asymchem Laboratories Tianjin Co's current Cash Flow from Operations (TTM) was 1,358. ==> 1,358 > 1,027 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=301.648/20931.5486
=0.01441116

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=116.472/21062.4056
=0.00552985

Asymchem Laboratories Tianjin Co's gearing of this year was 0.01441116. Asymchem Laboratories Tianjin Co's gearing of last year was 0.00552985. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=11797.964/1825.02
=6.46456696

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=13510.42/1969.68
=6.8591954

Asymchem Laboratories Tianjin Co's current ratio of this year was 6.46456696. Asymchem Laboratories Tianjin Co's current ratio of last year was 6.8591954. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Asymchem Laboratories Tianjin Co's number of shares in issue this year was 350.891. Asymchem Laboratories Tianjin Co's number of shares in issue last year was 362.782. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2663.56/6283.215
=0.42391674

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4406.924/8623.603
=0.51103048

Asymchem Laboratories Tianjin Co's gross margin of this year was 0.42391674. Asymchem Laboratories Tianjin Co's gross margin of last year was 0.51103048. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=6283.215/21620.901
=0.29060838

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=8623.603/20368.066
=0.42338841

Asymchem Laboratories Tianjin Co's asset turnover of this year was 0.29060838. Asymchem Laboratories Tianjin Co's asset turnover of last year was 0.42338841. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Asymchem Laboratories Tianjin Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Asymchem Laboratories Tianjin Co  (HKSE:06821) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Asymchem Laboratories Tianjin Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Asymchem Laboratories Tianjin Co Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
Norges Bank 2101 Beneficial owner
Fmr Llc 2201 Interest of corporation controlled by you
Fidelity Investment Trust 2101 Beneficial owner
Springhill Fund Asset Management (hk) Company Limited 2102 Investment manager
Springhill Fund Limited 2201 Interest of corporation controlled by you
Springhill Global Feeder Fund Limited 2201 Interest of corporation controlled by you
Springhill Master Fund Limited 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Jpmorgan Asset Management (asia Pacific) Limited 2102 Investment manager
Fidelity Management & Research Company Llc

Asymchem Laboratories Tianjin Co Headlines

No Headlines